Who owns Progenics Pharmaceuticals?

Key details on Progenics Pharmaceuticals (Ticker: PGNX)

Who owns Progenics Pharmaceuticals?

Is PGNX a good stock to own? Find out who bought Progenics Pharmaceuticals, who sold Progenics Pharmaceuticals (PGNX) stock, and who holds a large position in Progenics Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Federated Investors 13.51M $82.81M Dec. 31, 2015
Broadfin Capital 8.95M $54.87M Dec. 31, 2015
FMR 5.24M $32.14M Dec. 31, 2015
Baker Bros. Advisors 4.35M $26.67M Dec. 31, 2015
BlackRock Fund Advisors 2.70M $16.58M Dec. 31, 2015
Vanguard 2.37M $14.55M Dec. 31, 2015
Tudor Investment Corporation 2.37M $14.53M Dec. 31, 2015
STATE STREET CORPORATION 2.35M $14.39M Dec. 31, 2015
Royce & Associates 2.28M $13.99M Dec. 31, 2015
Millennium Management 2.27M $13.92M Dec. 31, 2015
BlackRock Institutional Trust Company, N.A. 1.79M $10.95M Dec. 31, 2015
Wellington Management Company 1.65M $12.30M June 30, 2015
Highland Capital Management 1.59M $8.25M Sept. 30, 2014